CFO Converts $42K Debt to Equity Amidst Going Concern Warnings, Boosting Ownership
COSM sits 22% above its 52-week low of $0.193 on elevated volume (8.8× avg).
Summary
Cosmos Health's CFO acquired $42,000 worth of common stock by converting company debt, increasing their stake amidst financial distress.
Key Events · Ownership and Investor Activity · COSM
-
CFO Acquires Shares
Georgios Terzis, Chief Financial Officer, acquired 168,135 shares of common stock.
-
Debt-for-Equity Swap
The acquisition was a debt exchange for $42,000 owed by the company to the CFO, not a cash purchase. Shares were acquired at the fair market value of $0.25 per share.
-
Increased Insider Ownership
This transaction increases the CFO's direct holdings to 2,235,398 shares, demonstrating increased personal investment in the company.
-
Context of Financial Challenges
This insider commitment occurs after recent 10-K and 10-Q filings disclosed 'going concern' warnings, increased losses, and significant potential dilution from an ATM program and noteholder resales.
Analysis · COSM · Trade & Services
The Chief Financial Officer's decision to convert $42,000 of company debt into common stock is a significant vote of confidence, especially given Cosmos Health's recent 'going concern' warnings and ongoing dilution from other capital raises. This action increases the CFO's direct ownership and aligns their interests more closely with shareholders, signaling belief in the company's future despite financial challenges.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 37.2% of the 984 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.83%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, COSM was trading at $0.24 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $15.5M. The 52-week trading range was $0.19 to $1.32. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.